Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFT/LV adjuvant therapy for high-risk stage II colorectal cancer
jRCTs031180155Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- May 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tegafur + uracil and folinic acid in colorectal cancer (CRC) (3 arms), sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoint: Disease-free survival. Started May 2012; status: completed.
02
Drugs
tegafur + uracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs031180155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180155.